OPKO Health Other Long-Term Assets 2010-2025 | OPK

OPKO Health other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
OPKO Health Annual Other Long-Term Assets
(Millions of US $)
2024 $214
2023 $204
2022 $204
2021 $600
2020 $600
2019 $597
2018 $643
2017 $653
2016 $650
2015 $797
2014 $799
2013 $800
2012 $14
2011 $1
2010 $0
2009 $0
OPKO Health Quarterly Other Long-Term Assets
(Millions of US $)
2025-03-31 $214
2024-12-31 $214
2024-09-30 $214
2024-06-30 $203
2024-03-31 $204
2023-12-31 $204
2023-09-30 $204
2023-06-30 $204
2023-03-31 $203
2022-12-31 $204
2022-09-30 $205
2022-06-30 $204
2022-03-31 $9
2021-12-31 $600
2021-09-30 $599
2021-06-30 $600
2021-03-31 $600
2020-12-31 $600
2020-09-30 $596
2020-06-30 $598
2020-03-31 $597
2019-12-31 $597
2019-09-30 $641
2019-06-30 $639
2019-03-31 $639
2018-12-31 $643
2018-09-30 $656
2018-06-30 $651
2018-03-31 $652
2017-12-31 $653
2017-09-30 $687
2017-06-30 $685
2017-03-31 $684
2016-12-31 $650
2016-09-30 $651
2016-06-30 $610
2016-03-31 $798
2015-12-31 $797
2015-09-30 $915
2015-06-30 $818
2015-03-31 $798
2014-12-31 $799
2014-09-30 $798
2014-06-30 $798
2014-03-31 $800
2013-12-31 $800
2013-09-30 $800
2013-06-30 $206
2013-03-31 $206
2012-12-31 $14
2012-09-30 $2
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.094B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $188.582B 82.60
Thermo Fisher Scientific (TMO) United States $154.218B 18.65
Edwards Lifesciences (EW) United States $44.793B 29.37
Alcon (ALC) Switzerland $43.149B 29.16
IDEXX Laboratories (IDXX) United States $41.707B 47.93
DexCom (DXCM) United States $33.596B 51.93
IQVIA Holdings (IQV) United States $26.668B 14.94
Mettler-Toledo (MTD) United States $24.844B 29.55
STERIS (STE) Ireland $23.875B 26.30
Waters (WAT) United States $20.729B 29.25
SONOVA HOLDING (SONVY) Switzerland $18.648B 0.00
Hologic (HOLX) United States $14.389B 15.63
Sysmex ADR (SSMXY) Japan $10.323B 29.29
Penumbra (PEN) United States $9.933B 77.96
Masimo (MASI) United States $9.319B 34.38
Globus Medical (GMED) United States $8.169B 19.47
Teleflex (TFX) United States $5.447B 8.99
Glaukos (GKOS) United States $5.408B 0.00
TransMedics (TMDX) United States $4.715B 102.50
Integer Holdings (ITGR) United States $4.259B 22.31
PROCEPT BioRobotics (PRCT) United States $3.478B 0.00
LivaNova (LIVN) United Kingdom $2.525B 15.03
Nihon Kohden (NHNKY) Japan $2.253B 25.84
Veracyte (VCYT) United States $2.181B 30.60
Elekta AB (EKTAY) Sweden $2.013B 18.10
Alphatec Holdings (ATEC) United States $1.742B 0.00
Tandem Diabetes Care (TNDM) United States $1.347B 0.00
Artivion (AORT) United States $1.246B 116.76
Pulse Biosciences (PLSE) United States $1.163B 0.00
Integra LifeSciences Holdings (IART) United States $1.079B 5.74
Beta Bionics (BBNX) United States $0.842B 0.00
SiBone (SIBN) United States $0.804B 0.00
IRadimed (IRMD) United States $0.773B 39.23
RxSight (RXST) United States $0.622B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.585B 9.09
Mesa Laboratories (MLAB) United States $0.561B 13.15
Delcath Systems (DCTH) United States $0.555B 0.00
OrthoPediatrics (KIDS) United States $0.523B 0.00
AxoGen (AXGN) United States $0.474B 0.00
AngioDynamics (ANGO) United States $0.452B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.433B 0.00
NeuroPace (NPCE) United States $0.424B 0.00
Semler Scientific (SMLR) United States $0.379B 10.09
ClearPoint Neuro (CLPT) United States $0.373B 0.00
Treace Medical Concepts (TMCI) United States $0.371B 0.00
Pacific Biosciences Of California (PACB) United States $0.360B 0.00
908 Devices (MASS) United States $0.250B 0.00
Neuronetics (STIM) United States $0.245B 0.00
Tactile Systems Technology (TCMD) United States $0.238B 14.41
Alpha Tau Medical (DRTS) Israel $0.220B 0.00
Sight Sciences (SGHT) United States $0.210B 0.00
Anteris Technologies Global (AVR) Australia $0.194B 0.00
Inogen (INGN) United States $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.172B 0.00
Biosig Technologies (BSGM) United States $0.172B 0.00
CVRx (CVRX) United States $0.162B 0.00
Rapid Micro Biosystems (RPID) United States $0.155B 0.00
LENSAR (LNSR) United States $0.154B 0.00
Lucid Diagnostics (LUCD) United States $0.141B 0.00
Accuray (ARAY) United States $0.132B 0.00
Atossa Genetics (ATOS) United States $0.118B 0.00
Monogram Orthopaedics (MGRM) United States $0.094B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.082B 50.00
EnVVeno Medical (NVNO) United States $0.078B 0.00
InspireMD (NSPR) United States $0.074B 0.00
EDAP TMS S.A (EDAP) France $0.067B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
Spectral AI (MDAI) United States $0.056B 0.00
Positron (POSC) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
Baird Medical Investment Holdings (BDMD) $0.031B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.36